1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc.

ETON
Eton Pharmaceuticals, Inc.US flagNASDAQ
43.10
USD
-0.10
- -
1.18BMarket Cap

Income Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
1
- -
22
21
32
39
80
+ Sales & Services Revenue
- -
- -
1
- -
22
21
32
39
80
- Cost of Revenue
- -
- -
- -
- -
3
7
11
16
37
+ Cost of Goods & Services
- -
- -
- -
- -
3
7
11
16
37
Gross Profit
- -
- -
1
- -
19
14
21
23
43
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
- -
10
19
27
20
23
22
26
44
+ Selling, General & Admin
- -
5
8
13
14
19
19
23
36
+ Research & Development
- -
6
12
14
6
4
3
3
8
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
- -
-10
-19
-27
-1
-8
-1
-3
-1
- Non-Operating (Income) Loss
- -
2
- -
1
- -
1
-1
1
4
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
3
- -
1
- -
1
-1
1
4
Pretax Income
- -
-13
-18
-28
-2
-9
-1
-4
-5
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-13
-18
-28
-2
-9
-1
-4
-5
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-13
-18
-28
-2
-9
-1
-4
-5
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-13
-18
-28
-2
-9
-1
-4
-5
- Preferred Dividends
- -
24
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-37
-18
-28
-2
-9
-1
-4
-5
EBIT
- -
-10
-19
-27
-1
-8
-1
-3
-1
EBITDA
- -
-10
-18
-26
-1
-6
- -
-1
3
EBITDA Margin (%)
- -
- -
-1,893.01
-67,846.15
-4.73
-30.52
-0.92
-3.72
4
EBITA
- -
-10
-19
-27
-1
-8
-1
-3
-1
Gross Margin (%)
- -
- -
52.76
-1,017.95
87.05
67.38
66.56
60.01
53.46
Operating Margin (%)
- -
- -
-1,939.62
-69,515.38
-6.85
-38.87
-3.77
-6.66
-1.06
Profit Margin (%)
- -
- -
-1,910.32
-71,717.95
-8.95
-42.45
-2.96
-9.8
-5.75
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
- -
2
1
1
4
Basic Weighted Avg Shares
- -
6
18
21
25
25
26
26
27
Basic EPS, GAAP
- -
-5.8
-1.03
-1.33
-0.08
-0.36
-0.04
-0.15
-0.17
Basic EPS from Cont Ops
- -
-1.99
-1.03
-1.33
-0.08
-0.36
-0.04
-0.15
-0.17
Diluted Weighted Avg Shares
- -
6
18
21
25
25
26
26
27
Diluted EPS, GAAP
- -
-5.8
-1.03
-1.33
-0.08
-0.36
-0.04
-0.15
-0.17
Diluted EPS from Cont Ops
- -
-1.99
-1.03
-1.33
-0.08
-0.36
-0.04
-0.15
-0.17

Balance Sheet (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
13
28
15
25
24
20
27
41
61
+ Cash, Cash Equivalents & STI
13
27
12
21
14
16
21
15
26
+ Cash & Cash Equivalents
13
27
12
21
14
16
21
15
26
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
5
2
3
5
12
+ Accounts Receivable, Net
- -
- -
- -
- -
5
2
3
5
12
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
1
1
1
1
15
15
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
5
1
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
3
9
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
7
7
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
-1
-1
+ Other Inventory
- -
- -
- -
1
1
1
1
- -
- -
+ Other ST Assets
- -
1
2
2
3
1
1
5
7
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
2
2
4
5
5
35
32
+ Property, Plant & Equip, Net
- -
1
1
1
- -
- -
- -
- -
1
+ Property, Plant & Equip
- -
1
2
2
1
1
1
1
1
- Accumulated Depreciation
- -
- -
- -
1
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
1
1
4
5
5
35
31
+ Total Intangible Assets
- -
- -
1
1
4
5
5
35
31
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
1
1
4
5
5
35
31
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
13
28
17
26
27
25
32
76
92
+ Payables & Accruals
1
2
2
4
3
5
11
20
30
+ Accounts Payable
1
1
1
2
2
2
2
4
11
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
1
1
1
4
9
16
19
+ ST Debt
- -
- -
- -
- -
1
1
5
- -
9
+ ST Borrowings
- -
- -
- -
- -
1
1
5
- -
9
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
1
2
2
4
5
6
16
20
38
+ LT Debt
- -
- -
5
7
5
5
- -
30
22
+ LT Borrowings
- -
- -
5
7
5
5
- -
30
22
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
1
- -
- -
- -
- -
- -
- -
2
5
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
1
- -
- -
- -
- -
- -
- -
2
5
Total Noncurrent Liabilities
1
- -
5
7
5
5
- -
32
27
Total Liabilities
1
2
7
11
10
12
16
52
66
+ Preferred Equity and Hybrid Capital
19
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
2
72
75
108
112
116
120
132
139
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
2
72
75
108
112
116
120
132
139
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-9
-46
-64
-92
-94
-103
-104
-108
-112
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
12
26
11
16
18
13
15
24
26
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
12
26
11
16
18
13
15
24
26
Total Liabilities & Equity
13
28
17
26
27
25
32
76
92
Shares Outstanding
16
18
18
24
25
25
26
27
27
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-13
-27
-8
-14
-8
-10
-16
15
5
Net Debt to Equity
-108.46
-101.64
-71.34
-90.99
-43.82
-75.61
-103.43
60.89
17.65
Tangible Common Equity Ratio
-51.13
92.85
60.1
58.61
58.75
41.05
39.77
-25.35
-7.71
Current Ratio
16.76
13.59
7.65
6.51
5.18
3.1
1.65
2.06
1.57
Cash Conversion Cycle
- -
- -
-194.2
2,706.53
-190.19
-1.06
-4.64
193.2
115.51

Cash Flow Statement (USD)

APIChatGPT
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
- -
-13
-18
-28
-2
-9
-1
-4
-5
+ Depreciation & Amortization
- -
- -
- -
1
- -
2
1
1
4
+ Non-Cash Items
- -
4
2
4
3
4
3
5
12
+ Stock-Based Compensation
- -
2
2
3
3
4
3
3
6
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
3
- -
1
- -
- -
- -
2
6
+ Chg in Non-Cash Work Cap
- -
- -
-2
1
-6
8
4
-1
-1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
-5
4
-2
-3
-6
+ (Inc) Dec in Inventories
- -
- -
- -
-1
1
- -
- -
-2
-6
+ (Inc) Dec in Prepaid Assets
- -
-1
-1
- -
-1
2
- -
-3
-2
+ Inc (Dec) in Accts Payable
- -
1
- -
1
- -
2
5
7
10
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
- -
3
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-8
-18
-22
-5
5
7
1
11
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
1
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-2
- -
-3
-3
-1
-10
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
-1
- -
-3
-3
-1
-10
- -
+ Cash (Repurchase) of Equity
- -
23
- -
29
- -
- -
- -
7
- -
+ Increase in Capital Stock
- -
23
- -
29
- -
- -
- -
7
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
-30
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
-30
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-2
- -
-3
-3
-1
-40
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
5
2
- -
- -
-1
24
- -
+ Cash From Debt
- -
- -
5
2
- -
- -
- -
25
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
-1
-1
- -
+ Other Financing Activities
- -
-1
- -
- -
1
- -
- -
1
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
22
5
32
- -
- -
-1
33
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
14
-15
9
-7
2
5
-6
11
EBITDA
- -
-10
-18
-26
-1
-6
- -
-1
3
EBITDA Margin (%)
- -
- -
-1,893.01
-67,846.15
-4.73
-30.52
-0.92
-3.72
4
Free Cash Flow
- -
-8
-20
-22
-8
2
6
-9
10
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
30
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-52
-14
-20
-4
4
6
25
10
Free Cash Flow per Basic Share
- -
-1.31
-1.12
-1.07
-0.32
0.08
0.24
-0.35
0.38
Price/Free Cash Flow
- -
-4.97
-7.9
-7.66
-73.97
9.32
14.8
31.41
41.91
Cash Flow to Net Income
- -
0.64
0.98
0.8
2.41
-0.53
-7.28
-0.25
-2.29
Capital Expenditures
- -
- -
-2
- -
-3
-3
-1
-10
- -